Role of sleep deprivation in immune-related disease risk and outcomes
Modern societies are experiencing an increasing trend of reduced sleep duration, with
nocturnal sleeping time below the recommended ranges for health. Epidemiological and …
nocturnal sleeping time below the recommended ranges for health. Epidemiological and …
The glymphatic system: Current understanding and modeling
We review theoretical and numerical models of the glymphatic system, which circulates
cerebrospinal fluid and interstitial fluid around the brain, facilitating solute transport. Models …
cerebrospinal fluid and interstitial fluid around the brain, facilitating solute transport. Models …
Clinical trials of new drugs for Alzheimer disease
LK Huang, SP Chao, CJ Hu - Journal of biomedical science, 2020 - Springer
Alzheimer disease (AD) accounts for 60–70% of dementia cases. Given the seriousness of
the disease and continual increase in patient numbers, developing effective therapies to …
the disease and continual increase in patient numbers, developing effective therapies to …
The sleep-immune crosstalk in health and disease
Sleep-immune interactions are well-known phenomena in everyday life and folk wisdom.
There is no doubt that an infection makes us tired and increases the desire to sleep, and a …
There is no doubt that an infection makes us tired and increases the desire to sleep, and a …
Perivascular spaces in the brain: anatomy, physiology and pathology
JM Wardlaw, H Benveniste, M Nedergaard… - Nature Reviews …, 2020 - nature.com
Perivascular spaces include a variety of passageways around arterioles, capillaries and
venules in the brain, along which a range of substances can move. Although perivascular …
venules in the brain, along which a range of substances can move. Although perivascular …
A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease
Brain accumulation of the amyloid-β (Aβ) peptide is believed to be the initial event in the
Alzheimer disease (AD) process. Aβ accumulation begins 15–20 years before clinical …
Alzheimer disease (AD) process. Aβ accumulation begins 15–20 years before clinical …
The glymphatic pathway in neurological disorders
Background The glymphatic (glial-lymphatic) pathway is a fluid-clearance pathway identified
in the rodent brain in 2012. This pathway subserves the flow of CSF into the brain along …
in the rodent brain in 2012. This pathway subserves the flow of CSF into the brain along …
[HTML][HTML] Alzheimer disease: an update on pathobiology and treatment strategies
JM Long, DM Holtzman - Cell, 2019 - cell.com
Alzheimer disease (AD) is a heterogeneous disease with a complex pathobiology. The
presence of extracellular β-amyloid deposition as neuritic plaques and intracellular …
presence of extracellular β-amyloid deposition as neuritic plaques and intracellular …
Bidirectional relationship between sleep and Alzheimer's disease: role of amyloid, tau, and other factors
C Wang, DM Holtzman - Neuropsychopharmacology, 2020 - nature.com
As we age, we experience changes in our nighttime sleep and daytime wakefulness.
Individuals afflicted with Alzheimer's disease (AD) can develop sleep problems even before …
Individuals afflicted with Alzheimer's disease (AD) can develop sleep problems even before …
Association between circadian rhythms and neurodegenerative diseases
Dysfunction in 24-h circadian rhythms is a common occurrence in ageing adults; however,
circadian rhythm disruptions are more severe in people with age-related neurodegenerative …
circadian rhythm disruptions are more severe in people with age-related neurodegenerative …